LIVER CANCER RISK INCREASES AFTER CLEARANCE OF HEPATITIS B VIRUS. HERE IS WHY…

For some people, hepatitis B is a short illness, but for others, it can become long term or chronic and lead to serious liver problems, including cirrhosis and liver cancer. Now, new research finds the risk of liver cancer persists even after the virus is cleared, suggesting people who have had the illness should continue to be monitored.
Chronic infection with hepatitis B can lead to serious liver problems, including cirrhosis and liver cancer.
The new study – by researchers from the Centers for Disease Control and Prevention (CDC) and the Alaska Native Tribal Health Consortium, both in Anchorage, AK – is published in the journal Alimentary Pharmacology & Therapeutics. Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV), which spreads when body fluids from an infected person enter the body of another person, such as during sex, from sharing needles and other injecting equipment and from mother to baby at birth.
Around 25 percent of people who become chronically infected as children, and 15 percent who become chronically infected as adults die prematurely from cirrhosis or liver cancer, and in most cases, they experience no symptoms until these serious diseases occur. Globally, around 240 million people are living with chronic HBV, and an estimated 786,000 die from HBV-related liver disease each year.
The team found that clearance of HBV appeared to make no difference to the risk of developing liver cancer.
The researchers note while we do not know why HBV clearance appears not to affect risk of liver cancer, they suggest it is likely due to a number of factors.
One reason, for instance, could be the integration of HBV DNA into the genome of liver cells, which occurs early in infection, and can persist after traces of the virus clear from the bloodstream.
The authors note that a “substantial proportion” of the case patients in their study had a detectable level of HBV DNA after virus traces (antibodies against the virus) had cleared from the bloodstream.
This raises the possibility that “ongoing low-level HBV DNA replication with
continued integration” into the host liver cell contributes to the persistent risk of liver cancer after the virus has cleared from the bloodstream.
It is thus highly recommended that persons treated of Hepatitis B virus be followed up.
REFERENCE : Catherine Paddock, MNT NEWS.

(Visited 68 times, 1 visits today)
Facebooktwittergoogle_pluslinkedinrssyoutubeby feather
Facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Cynthia Isuekebhor